Nifty

:

22795.90

Sensex

:

75311.06

-117.25 (-0.51%)
-424.90 (-0.56%)

Login

Nifty
Sensex

:
:

22795.90
75311.06

-117.25 (-0.51%)
-424.90 (-0.56%)

Eris Lifesciences Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

N/A

BSE: 540596 | NSE: ERIS

Watchlist

NSE BSE

1453.75

06-Feb-2025

Open
High
Low
Previous Close

1162.00
1498.40
1162.00
1390.20

Volume
Traded Value (lacs)
52 Week High
52 Week Low

1118917
15598.67
1593.90
809.15

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

17,422.51
52.90
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

19,911.23
N/A
6.10

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

13.92
13.34
14.26

EBITDA CAGR (%)

10 Years
5 Years
3 Years

18.71
12.90
6.83

PAT CAGR (%)

10 Years
5 Years
3 Years

15.95
5.74
-1.17

P:E (Median)

8 Years
5 Years
3 Years

27.02
24.90
29.04

P:BV (Average)

8 Years
5 Years
3 Years

6.26
5.22
5.08

EV:EBITDA (Average)

8 Years
5 Years
3 Years

21.66
19.57
19.70

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS 28.82 28.14 40.75 53.59
P/E Ratio 50.99 52.22 36.06 27.42
Revenue 1991 2999 3412 3854
EBITDA 675 1052 1223 1408
Net Income 392 389 560 732
ROA 7.3 6.8 8.6 10.7
P/Bk Ratio 7.73 6.42 5.6 4.78
ROE 16.39 13.39 18.08 19.13
FCFF 286.54 -622.35 832.55 945.52
FCFF Yield 1.3 -2.81 3.77 4.28

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 399.73 324.41 23.22% 436.56 409.71 6.55% 456.69 411.29 11.04% 341.30 314.58 8.49%
Expenses 300.16 249.98 20.07% 293.93 265.22 10.82% 333.31 255.78 30.31% 261.91 203.09 28.96%
EBITDA 99.57 74.43 33.78% 142.63 144.49 -1.29% 123.38 155.51 -20.66% 79.39 111.49 -28.79%
EBIDTM 24.91% 22.94% 32.67% 35.27% 27.02% 37.81% 23.26% 35.44%
Other Income 7.79 3.43 127.11% 5.81 6.98 -16.76% 5.16 4.03 28.04% 20.39 4.26 378.64%
Interest 54.65 15.14 260.96% 56.26 6.55 758.93% 56.17 6.84 721.20% 28.89 2.96 876.01%
Depreciation 46.68 28.08 66.24% 46.16 25.00 84.64% 45.55 20.16 125.94% 29.14 17.28 68.63%
PBT 6.03 34.64 -82.59% 46.02 119.92 -61.62% 26.82 132.54 -79.76% 41.75 95.51 -56.29%
Tax 4.25 2.99 42.14% 17.92 2.11 749.29% 9.78 21.78 -55.10% 2.24 7.67 -70.80%
PAT 1.78 31.65 -94.38% 28.10 117.81 -76.15% 17.04 110.76 -84.62% 39.51 87.84 -55.02%
PATM 0.45% 9.76% 6.44% 28.75% 3.73% 26.93% 11.58% 27.92%
EPS 0.13 2.33 -94.42% 2.06 8.66 -76.21% 1.25 8.14 -84.64% 2.90 6.45 -55.04%

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 727.45 486.30 49.59% 741.17 505.30 46.68% 719.72 466.62 54.24% 550.92 402.80 36.77%
Expenses 477.14 310.79 53.52% 476.66 324.16 47.04% 469.73 296.87 58.23% 402.49 283.90 41.77%
EBITDA 250.31 175.51 42.62% 264.51 181.14 46.03% 249.99 169.75 47.27% 148.43 118.89 24.85%
EBIDTM 34.41% 36.09% 35.69% 35.85% 34.73% 36.38% 26.94% 29.52%
Other Income 4.22 4.20 0.48% 4.55 3.48 30.75% 1.64 0.99 65.66% 15.15 1.00 1,415.00%
Interest 57.17 18.12 215.51% 59.47 16.30 264.85% 60.37 17.36 247.75% 33.03 8.87 272.38%
Depreciation 81.20 45.72 77.60% 80.48 42.09 91.21% 75.94 40.89 85.72% 53.90 35.13 53.43%
PBT 116.16 115.87 0.25% 129.11 126.23 2.28% 115.32 112.49 2.52% 76.65 75.90 0.99%
Tax 29.23 14.41 102.85% 32.76 3.93 733.59% 25.90 18.84 37.47% -2.99 14.42 -
PAT 86.93 101.46 -14.32% 96.35 122.30 -21.22% 89.42 93.65 -4.52% 79.63 61.48 29.52%
PATM 11.95% 20.86% 13.00% 24.20% 12.42% 20.07% 14.45% 15.26%
EPS 6.14 7.55 -18.68% 6.73 9.08 -25.88% 6.11 6.97 -12.34% 5.22 4.81 8.52%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 1,634.28 1,486.71 1,330.72 1,215.73 1,108.83 1,020.23 896.54 760.60 712.90 605.48 547.99 Net Sales Growth 11.94% 11.72% 9.46% 9.64% 8.68% 13.80% 17.87% 6.69% 17.74% 10.49% Cost Of Goods Sold 440.24 280.16 236.38 199.65 198.51 164.35 132.35 115.94 135.66 116.14 114.22 Gross Profit 1,194.04 1,206.54 1,094.34 1,016.08 910.32 855.88 764.19 644.67 577.24 489.33 433.76 GP Margin 73.06% 81.16% 82.24% 83.58% 82.10% 83.89% 85.24% 84.76% 80.97% 80.82% 79.15% Total Expenditure 1,189.31 1,032.89 825.61 731.67 691.36 665.28 562.77 444.67 441.70 435.01 434.13 Power & Fuel Cost - 4.46 4.41 4.01 3.89 4.54 3.34 3.04 2.93 2.74 4.13 % Of Sales - 0.30% 0.33% 0.33% 0.35% 0.44% 0.37% 0.40% 0.41% 0.45% 0.75% Employee Cost - 331.67 252.52 220.11 207.02 191.73 166.77 130.84 116.31 122.36 123.75 % Of Sales - 22.31% 18.98% 18.11% 18.67% 18.79% 18.60% 17.20% 16.32% 20.21% 22.58% Manufacturing Exp. - 19.98 14.18 38.89 11.87 14.63 8.09 4.97 4.47 6.40 5.78 % Of Sales - 1.34% 1.07% 3.20% 1.07% 1.43% 0.90% 0.65% 0.63% 1.06% 1.05% General & Admin Exp. - 211.45 154.78 135.40 110.76 125.31 122.99 92.81 106.48 102.91 115.10 % Of Sales - 14.22% 11.63% 11.14% 9.99% 12.28% 13.72% 12.20% 14.94% 17.00% 21.00% Selling & Distn. Exp. - 140.07 137.77 98.34 109.88 131.07 125.15 95.36 72.99 82.35 70.47 % Of Sales - 9.42% 10.35% 8.09% 9.91% 12.85% 13.96% 12.54% 10.24% 13.60% 12.86% Miscellaneous Exp. - 45.10 25.57 35.28 49.43 33.64 4.09 1.71 2.85 2.10 70.47 % Of Sales - 3.03% 1.92% 2.90% 4.46% 3.30% 0.46% 0.22% 0.40% 0.35% 0.12% EBITDA 444.97 453.82 505.11 484.06 417.47 354.95 333.77 315.93 271.20 170.47 113.86 EBITDA Margin 27.23% 30.53% 37.96% 39.82% 37.65% 34.79% 37.23% 41.54% 38.04% 28.15% 20.78% Other Income 39.15 34.83 17.26 28.99 10.00 15.49 32.50 28.22 25.08 3.28 3.43 Interest 195.97 57.42 20.81 3.05 0.94 1.97 22.90 10.48 0.85 0.28 0.01 Depreciation 167.53 102.39 64.66 51.45 37.64 44.88 31.59 21.79 21.44 19.55 14.67 PBT 120.62 328.83 436.91 458.54 388.89 323.59 311.78 311.89 273.99 153.93 102.61 Tax 34.19 29.12 38.90 41.35 38.29 32.32 26.39 18.23 25.84 15.96 19.28 Tax Rate 28.35% 8.86% 8.90% 9.02% 9.85% 9.99% 8.46% 5.85% 9.43% 10.37% 18.79% PAT 86.43 299.71 398.01 417.19 350.61 291.27 285.38 293.65 248.14 137.97 83.33 PAT before Minority Interest 86.43 299.71 398.01 417.19 350.61 291.27 285.38 293.65 248.14 137.97 83.33 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 5.29% 20.16% 29.91% 34.32% 31.62% 28.55% 31.83% 38.61% 34.81% 22.79% 15.21% PAT Growth -75.17% -24.70% -4.60% 18.99% 20.37% 2.06% -2.82% 18.34% 79.85% 65.57% EPS 6.35 22.02 29.24 30.65 25.76 21.40 20.97 21.58 18.23 10.14 6.12

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 2,739.26 2,009.14 1,685.15 1,347.04 1,211.86 1,074.06 982.16 855.60 749.50 597.02 545.56 Net Sales Growth 47.19% 19.23% 25.10% 11.15% 12.83% 9.36% 14.79% 14.16% 25.54% 9.43% Cost Of Goods Sold 661.92 380.04 352.35 258.51 238.27 171.53 153.70 141.57 133.60 98.48 99.73 Gross Profit 2,077.34 1,629.10 1,332.80 1,088.53 973.60 902.53 828.46 714.03 615.90 498.54 445.83 GP Margin 75.84% 81.08% 79.09% 80.81% 80.34% 84.03% 84.35% 83.45% 82.17% 83.50% 81.72% Total Expenditure 1,826.02 1,334.31 1,148.40 862.01 781.11 706.17 637.08 533.49 480.36 425.32 424.10 Power & Fuel Cost - 12.04 5.70 4.16 3.95 4.62 3.45 3.17 3.02 3.59 4.89 % Of Sales - 0.60% 0.34% 0.31% 0.33% 0.43% 0.35% 0.37% 0.40% 0.60% 0.90% Employee Cost - 403.81 346.16 250.18 229.30 205.69 190.66 157.32 131.22 124.67 125.63 % Of Sales - 20.10% 20.54% 18.57% 18.92% 19.15% 19.41% 18.39% 17.51% 20.88% 23.03% Manufacturing Exp. - 23.89 15.61 38.81 11.51 13.96 7.81 4.89 5.05 7.87 6.78 % Of Sales - 1.19% 0.93% 2.88% 0.95% 1.30% 0.80% 0.57% 0.67% 1.32% 1.24% General & Admin Exp. - 253.43 206.62 154.21 121.70 135.85 142.38 116.86 121.29 104.36 115.43 % Of Sales - 12.61% 12.26% 11.45% 10.04% 12.65% 14.50% 13.66% 16.18% 17.48% 21.16% Selling & Distn. Exp. - 207.20 185.16 121.39 128.70 140.99 134.82 107.67 84.32 82.75 70.90 % Of Sales - 10.31% 10.99% 9.01% 10.62% 13.13% 13.73% 12.58% 11.25% 13.86% 13.00% Miscellaneous Exp. - 53.90 36.80 34.74 47.69 33.53 4.25 2.00 1.86 3.59 70.90 % Of Sales - 2.68% 2.18% 2.58% 3.94% 3.12% 0.43% 0.23% 0.25% 0.60% 0.14% EBITDA 913.24 674.83 536.75 485.03 430.75 367.89 345.08 322.11 269.14 171.70 121.46 EBITDA Margin 33.34% 33.59% 31.85% 36.01% 35.54% 34.25% 35.13% 37.65% 35.91% 28.76% 22.26% Other Income 25.56 23.82 11.15 26.09 8.71 16.01 31.69 26.41 25.11 3.37 3.49 Interest 210.04 84.80 26.17 4.22 1.98 2.30 23.06 10.65 1.10 0.28 0.02 Depreciation 291.52 182.60 117.09 64.70 42.98 50.26 36.35 25.64 22.76 20.36 15.51 PBT 437.24 431.24 404.64 442.20 394.50 331.35 317.36 312.23 270.39 154.44 109.42 Tax 84.90 34.19 30.48 36.41 39.36 34.84 26.21 17.25 23.78 19.59 20.16 Tax Rate 19.42% 7.93% 7.53% 8.23% 9.98% 10.51% 8.26% 5.52% 8.79% 12.68% 18.42% PAT 352.33 391.98 382.16 406.11 355.13 296.50 290.80 294.11 246.79 133.57 89.23 PAT before Minority Interest 329.36 397.05 374.16 405.79 355.13 296.51 291.15 294.98 246.61 134.86 89.26 Minority Interest -22.97 -5.07 8.00 0.32 0.00 -0.01 -0.35 -0.87 0.18 -1.29 -0.03 PAT Margin 12.86% 19.51% 22.68% 30.15% 29.30% 27.61% 29.61% 34.37% 32.93% 22.37% 16.36% PAT Growth -7.01% 2.57% -5.90% 14.36% 19.77% 1.96% -1.13% 19.17% 84.76% 49.69% EPS 25.89 28.80 28.08 29.84 26.09 21.79 21.37 21.61 18.13 9.81 6.56

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 2,524.02 2,221.88 1,918.56 1,575.47 1,299.70 1,156.01 868.18 574.60 305.73 267.75 Share Capital 13.60 13.60 13.59 13.58 13.58 13.75 13.75 13.75 0.14 0.14 Total Reserves 2,505.36 2,205.48 1,903.07 1,557.91 1,283.27 1,141.06 854.43 560.85 305.59 267.61 Non-Current Liabilities 259.98 4.22 -170.49 -161.81 -130.18 -114.05 196.33 -22.95 20.17 18.53 Secured Loans 485.94 209.47 0.00 0.00 0.00 0.00 273.69 0.00 0.00 0.50 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 40.56 31.03 28.84 29.14 24.13 16.47 15.02 19.80 23.10 19.99 Current Liabilities 2,322.54 361.73 249.79 212.42 203.06 360.46 277.88 114.26 70.81 64.30 Trade Payables 138.84 83.07 96.77 86.71 89.93 74.93 79.03 25.11 27.89 36.10 Other Current Liabilities 692.64 83.43 26.61 23.37 24.41 195.04 112.61 12.39 8.47 7.66 Short Term Borrowings 1,387.61 55.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 103.45 140.22 126.41 102.34 88.72 90.50 86.24 76.76 34.44 20.55 Total Liabilities 5,106.54 2,587.83 1,997.86 1,626.08 1,372.58 1,402.42 1,342.39 665.91 396.71 350.58 Net Block 1,515.56 897.81 642.00 584.32 600.64 483.85 489.75 91.78 64.79 61.27 Gross Block 1,811.19 1,094.83 783.40 716.88 695.65 551.80 532.93 113.20 108.20 85.52 Accumulated Depreciation 295.64 197.01 141.40 132.55 95.01 67.96 43.19 21.43 43.41 24.25 Non Current Assets 3,169.23 1,957.80 1,334.30 1,134.47 869.37 782.82 958.53 399.30 159.69 191.98 Capital Work in Progress 0.61 0.34 2.98 1.55 4.37 2.73 0.00 0.00 0.00 0.00 Non Current Investment 1,618.94 966.51 678.18 480.97 246.03 274.36 451.84 290.43 62.59 113.05 Long Term Loans & Adv. 27.05 85.95 11.13 25.36 15.44 16.00 10.95 12.19 32.30 17.66 Other Non Current Assets 7.08 7.17 0.00 42.27 2.88 5.88 6.00 4.91 0.00 0.00 Current Assets 1,937.31 630.03 663.56 491.60 503.22 619.60 383.86 266.61 237.02 158.60 Current Investments 0.00 30.00 99.55 50.40 74.27 306.11 93.76 90.18 143.73 69.24 Inventories 91.64 63.70 84.79 64.85 65.46 74.70 57.52 47.20 49.46 53.83 Sundry Debtors 239.97 229.22 137.56 113.76 140.82 75.90 60.50 41.30 25.36 23.62 Cash & Bank 1,296.74 47.65 46.10 32.66 64.95 6.47 8.81 2.06 8.53 4.91 Other Current Assets 308.97 17.47 20.97 25.70 157.71 156.42 163.28 85.87 9.94 7.00 Short Term Loans & Adv. 284.00 241.99 274.60 204.25 109.46 103.14 123.50 78.83 7.81 4.84 Net Current Assets -385.23 268.30 413.77 279.18 300.16 259.13 105.98 152.35 166.21 94.30 Total Assets 5,106.54 2,587.83 1,997.86 1,626.07 1,372.59 1,402.42 1,342.39 665.91 396.71 350.58

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 2,586.12 2,195.99 1,908.31 1,576.42 1,296.33 1,150.52 861.31 567.14 299.62 266.04 Share Capital 13.60 13.60 13.59 13.58 13.58 13.75 13.75 13.75 0.14 0.14 Total Reserves 2,567.50 2,179.59 1,892.82 1,558.87 1,279.90 1,135.57 847.56 553.39 299.49 265.91 Non-Current Liabilities 987.79 730.02 -78.80 -109.06 -79.63 -65.50 248.09 11.82 19.84 18.52 Secured Loans 654.51 644.45 45.00 0.00 0.00 0.29 274.19 0.49 0.00 0.50 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 52.72 44.67 32.16 31.47 25.98 19.39 18.71 22.96 23.10 19.99 Current Liabilities 2,608.97 521.18 283.34 235.45 220.17 377.25 293.98 129.27 68.95 65.49 Trade Payables 268.35 124.77 117.77 102.62 100.05 84.13 90.77 38.52 24.57 36.71 Other Current Liabilities 850.78 190.12 35.81 29.07 27.44 198.57 115.06 13.52 9.71 7.74 Short Term Borrowings 1,311.31 55.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 178.53 151.29 129.75 103.76 92.68 94.55 88.15 77.24 34.67 21.04 Total Liabilities 6,818.79 3,471.88 2,112.74 1,702.81 1,436.87 1,480.58 1,428.04 732.02 391.61 353.97 Net Block 4,327.52 2,568.10 917.94 853.87 874.85 760.54 771.09 231.65 71.37 71.74 Gross Block 4,781.32 2,843.17 1,091.96 1,005.79 983.89 838.26 819.52 254.43 123.31 103.73 Accumulated Depreciation 453.80 275.07 174.02 151.92 109.04 77.73 48.42 22.78 51.95 31.99 Non Current Assets 4,439.82 2,629.21 1,401.72 1,167.24 901.78 827.09 1,060.81 462.52 169.38 190.50 Capital Work in Progress 19.67 21.72 26.99 1.55 4.37 2.73 0.00 0.07 0.00 0.00 Non Current Investment 15.54 6.69 420.84 243.65 3.20 40.91 271.61 213.05 62.60 97.28 Long Term Loans & Adv. 69.65 25.32 35.94 25.90 16.47 17.03 12.11 12.84 35.41 21.48 Other Non Current Assets 7.43 7.37 0.00 42.27 2.88 5.88 6.00 4.91 0.00 0.00 Current Assets 2,378.97 842.67 711.02 535.56 535.10 653.49 367.23 269.50 222.24 163.48 Current Investments 0.00 30.01 99.55 50.40 74.78 314.94 93.76 90.18 127.44 69.24 Inventories 189.03 131.44 117.91 94.47 69.47 82.65 65.45 55.82 47.62 57.60 Sundry Debtors 422.02 292.71 160.97 140.49 156.88 83.98 66.64 48.86 25.37 23.67 Cash & Bank 1,400.63 58.46 52.33 38.28 67.33 7.51 10.64 2.42 9.69 5.72 Other Current Assets 367.28 22.42 24.04 36.24 166.63 164.41 130.74 72.22 12.11 7.25 Short Term Loans & Adv. 335.99 307.65 256.23 175.70 111.48 106.85 86.48 64.91 9.85 4.97 Net Current Assets -230.00 321.49 427.68 300.12 314.93 276.24 73.25 140.22 153.29 97.98 Total Assets 6,818.79 3,471.88 2,112.74 1,702.80 1,436.88 1,480.58 1,428.04 732.02 391.62 353.98

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 336.29 322.33 369.41 395.41 265.25 216.31 236.28 209.72 132.65 92.37 PBT 328.83 436.91 458.54 388.89 323.59 311.78 311.89 273.99 153.93 102.61 Adjustment 144.13 73.70 31.04 36.11 39.36 24.57 7.63 -0.90 17.81 11.35 Changes in Working Capital -63.19 -110.50 -37.26 38.44 -47.37 -50.18 -15.57 -11.17 -7.53 1.42 Cash after chg. in Working capital 409.77 400.11 452.31 463.44 315.59 286.17 303.95 261.92 164.21 115.37 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -73.48 -77.79 -82.90 -68.03 -50.34 -69.86 -67.67 -52.21 -31.55 -23.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -2,491.89 -513.30 -267.64 -347.86 126.74 2.08 -592.73 -198.67 -45.39 -94.36 Net Fixed Assets -716.63 -308.79 -67.95 -18.41 -145.49 -21.60 -419.73 -5.00 -22.68 -12.05 Net Investments -622.43 -218.78 -246.36 -211.07 260.17 -34.87 -164.99 -174.29 -24.03 -84.69 Others -1,152.83 14.27 46.67 -118.38 12.06 58.55 -8.01 -19.38 1.32 2.38 Cash from Financing Activity 2,160.05 193.75 -88.42 -81.13 -333.52 -220.74 363.26 -17.52 -83.70 0.99 Net Cash Inflow / Outflow 4.45 2.78 13.36 -33.58 58.47 -2.34 6.81 -6.48 3.57 -1.00 Opening Cash & Equivalents 47.48 44.70 31.35 64.93 6.46 8.81 2.00 8.48 4.91 5.90 Closing Cash & Equivalent 51.94 47.48 44.70 31.35 64.93 6.46 8.81 2.00 8.48 4.91

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 486.00 291.74 378.26 375.36 271.17 223.00 234.63 200.21 131.48 90.06 PBT 431.24 404.64 442.20 394.50 331.35 317.36 312.23 270.39 154.44 109.42 Adjustment 254.26 139.84 49.25 44.07 44.24 30.50 14.12 -0.65 19.92 12.15 Changes in Working Capital -98.74 -175.54 -29.90 5.33 -52.65 -53.24 -22.15 -16.45 -8.21 -8.06 Cash after chg. in Working capital 586.76 368.95 461.55 443.90 322.94 294.62 304.20 253.29 166.16 113.50 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -100.75 -77.21 -83.28 -68.53 -51.77 -71.63 -69.56 -53.08 -34.68 -23.44 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -1,854.52 -982.10 -319.61 -323.36 123.23 -5.05 -590.10 -184.46 -43.91 -92.13 Net Fixed Assets -716.63 -308.79 -67.95 -18.41 -145.49 -21.60 -419.73 -5.00 -22.68 -12.05 Net Investments -622.43 -218.78 -246.36 -211.07 260.17 -34.87 -164.99 -174.29 -24.03 -84.69 Others -515.46 -454.53 -5.30 -93.88 8.55 51.42 -5.38 -5.17 2.80 4.61 Cash from Financing Activity 1,379.78 688.02 -44.70 -82.39 -334.59 -221.05 363.21 -23.66 -83.70 0.46 Net Cash Inflow / Outflow 11.26 -2.34 13.96 -30.39 59.81 -3.11 7.75 -7.91 3.87 -1.62 Opening Cash & Equivalents 56.02 50.87 36.91 67.31 7.50 10.61 2.34 8.87 5.00 6.62 Closing Cash & Equivalent 94.25 56.02 50.87 36.91 67.31 7.50 10.61 2.34 8.87 5.00

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 185.18 163.18 141.00 115.74 95.51 83.97 63.14 41.79 22154.28 19402.10 ROA 7.79% 17.36% 23.02% 23.38% 20.99% 20.79% 29.24% 46.70% 36.93% 26.97% ROE 12.65% 19.25% 23.92% 24.45% 23.76% 28.21% 40.71% 56.37% 48.12% 36.85% ROCE 10.18% 20.54% 26.42% 27.12% 24.74% 25.98% 35.45% 62.40% 53.64% 45.28% Fixed Asset Turnover 1.08 1.46 1.67 1.61 1.64 1.65 2.35 6.44 6.43 7.01 Receivable days 54.81 48.81 36.56 40.89 38.77 27.76 24.43 17.07 14.34 15.05 Inventory Days 18.15 19.76 21.77 20.93 25.07 26.92 25.13 24.74 30.25 32.55 Payable days 144.56 138.85 167.72 162.39 56.42 58.45 51.57 30.40 33.54 37.94 Cash Conversion Cycle -71.60 -70.28 -109.39 -100.57 7.42 -3.77 -2.02 11.41 11.05 9.66 Total Debt/Equity 1.00 0.14 0.00 0.00 0.00 0.15 0.43 0.00 0.00 0.00 Interest Cover 6.73 22.00 151.29 416.49 165.51 14.61 30.77 321.83 556.69 0.00

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 189.75 161.28 140.25 115.81 95.26 83.58 62.64 41.25 21711.81 19278.55 ROA 7.72% 13.40% 21.27% 22.62% 20.33% 20.02% 27.31% 43.89% 36.17% 28.59% ROE 16.63% 18.25% 23.33% 24.78% 24.28% 28.96% 41.30% 56.90% 47.68% 40.30% ROCE 12.36% 17.30% 25.29% 27.60% 25.44% 26.54% 35.76% 62.56% 54.56% 49.25% Fixed Asset Turnover 0.55 0.90 1.33 1.25 1.18 1.18 1.59 3.97 5.42 5.68 Receivable days 61.69 46.91 39.44 43.59 40.93 27.99 24.64 18.07 14.56 15.14 Inventory Days 27.66 25.78 27.78 24.03 25.85 27.52 25.87 25.19 31.24 33.71 Payable days 188.78 125.63 155.58 155.23 59.47 59.07 54.07 32.17 33.59 41.33 Cash Conversion Cycle -99.43 -52.94 -88.36 -87.61 7.30 -3.57 -3.57 11.09 12.21 7.52 Total Debt/Equity 1.06 0.38 0.02 0.00 0.00 0.15 0.44 0.00 0.00 0.00 Interest Cover 6.09 16.46 105.81 200.75 145.25 14.76 30.31 246.14 558.56 4974.41

Top Investors:

hdfc small cap fund

lilac investments limited

uti flexi cap fund

franklin india smaller companies fund

hetal rasiklal shah

bhikhalal chimanlal shah

Annual Reports:

News Update:

Eris Lifesciences - Quarterly Results
4th Feb 2025, 12:45 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback